Skip to content

Noninvasive Diagnosis of Giant Cell Arteritis: A Multicenter Trial

Noninvasive Diagnosis of Giant Cell Arteritis: A Multicenter Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00000594
Enrollment
400
Registered
2011-05-23
Start date
2007-11-24
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M31.6

Interventions

Group 1: observation group: Clinically indicated MRI at several diagnostic centers for examination of superficial cranial arteries when temporal arteritis is suspected. Similar MRI protocol are used,

Sponsors

Universitätsklinikum Würzburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 90 Years

Inclusion criteria

Inclusion criteria: Suspicion of temporal arteritis according to clinical criteria of the American College of Rheumatology with clinical indicated biopsie of the temporal artery to confirm diagnosis before steroid treatment.

Exclusion criteria

Exclusion criteria: Typical MRI exclusion criteria (pace maker, metallic foreign bodies, claustrophobia, allergy against MR contrast material, renal dysfuction with GFR below 30, corticoseroid treatment for more than 14 days

Design outcomes

Primary

MeasureTime frame
Assessment of non-invasive imaging in giant cell arteritis (MRI and colour coded duplex sonography)

Secondary

MeasureTime frame
1. Assessment of the cranial and extracranial involvement. 2. Reduce false negative biopsy results due to segmental distriubtion. 3. Correlation of imaging findings with clincial and serological parameters.

Countries

Germany

Contacts

Public ContactThorsten Bley

Universitätsklinikum Würzburg

thorsten.bley@roentgen.uni-wuerzburg.de0931/201-34000

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 7, 2026